Macroaxis: Personalized Investing
Simple Personalized Investing

ABT MDT SYK ISRG Exotic Iron Currency Services 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for EW

Edwards quote and profile

 
 Companies |  Insiders  | Dashboard  
     
65.53
  
STOCK
(0.19)  Macroaxis: -0.29 Down   0.29%  
Year To Date
62.34111
Last 1 Month(s)
62.5471.57
Trading Day 
64.8966.16
May 24 2013 

Diversification Suggestion

Use Edwards to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze Edwards Lifesciences rp Trend or Check current 30 days Edwards correlation with market (S&P 500)
1 Month Beta 1.64  
Highest Price:  
Lowest Price:  
71.57  
62.54  
May 14 2013 
May 01 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Edwards will likely underperform.
Edwards Lifesciences Corp Large BetaEdwards Lifesciences rp Beta Legend
EW United States NYSE
Edwards Lifesciences Corp
Healthcare
Medical Appliances and Equipment
Benchmark S&P 500
http://www.edwards.com
Contact Number: 949. 250. 2500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation6.94 B
Shares Outstanding113.9 M
Number of Shares Shorted4.68 M
Revenue1.94 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
 thisRed EW EW agains markets  0.29 % Macroaxis: 0.29 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Edwards Leadership

Michael Mussallem Chairman and CEO
Robert Reindl Corporate Vice President - Human Resources
Bruce Garren Corporate Vice President - Public Affairs and Special Counsel
Aimee Weisner Corporate Vice President General Counsel

Edwards Price and Market Media

The median price of Edwards for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 65.45 with a coefficient of variation of 3.63. The daily time series for the period is distributed with a sample standard deviation of 2.39, arithmetic mean of 65.82, and mean deviation of 1.85. The Stock received substential amount of media coverage during this period.
Edwards         SP 500
Price Growth (%)
 
1
Edwards Lifesciences Corp. Sank To A New Low On Weak Q2 Guid...04/26/2013Macroaxis: News
2
Edwards Lifesciences Given New 73.00 Price Target at Credit ...05/01/2013Macroaxis: News
3
Edwards Lifesciences Price Target Cut to 73.00 by Analysts a...05/03/2013Macroaxis: News
4
EDWARDS LIFESCIENCES CORP Edwards Lifesciences to Present at...05/09/2013Macroaxis: News
5
Edwards Lifesciences CFO To Retire Board Approves New 750 Ml...05/15/2013Macroaxis: News
6
EDWARDS LIFESCIENCES CORP Positive Patient Outcomes at One Y...05/22/2013Macroaxis: News

Edwards Summary

Edwards Lifesciences Corp [EW] is traded on New York Stock Exchange in USA. It is located in Irvine, CA and employs 8,200 people. The company currently falls under 'Mid-Cap' category with market capitalization of 7.27 B. Edwards Lifesciences Corp is active under Healthcare sector as part of Medical Appliances and Equipment industry. This company has 113.9 M outstanding shares of which 4.68 M shares are currently sold short in the market by investors with about 4.6 days to cover all shorted shares.
Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. more
Past Market
Over 30
Days
2
Out Of
100
 
Chance of
Less
Than
%
 
Follow Edwards with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Edwards to your reader
 

Edwards Research Report

Edwards vs. Abbott

Correlation analysis and fundamentals comparison between Edwards Lifesciences rp and Abbott Laboratories

Edwards Executives

Thomas Abate CFO, Principal Accounting Officer and Corporate VP, MBA

Edwards Directors

Mike Bowlin Independent Director
Wesley Schack Presiding Independent Director, MBA
David Pyott Independent Director, MBA
Barbara McNeil Independent Director, Ph.D
Robert Ingram Independent Director

Edwards Fundamentals

Price to Earnings To Growth vs Total Asset
Earnings Per Share vs Current Asset
Price to Earnings To Growth vs EBITDA
Book Value Per Share vs Current Asset

Edwards vs Competition

Edwards vs. Abbott Laboratories
Edwards vs. Medtronic Inc
Edwards vs. Stryker Corporation
Edwards vs. Intuitive Surgical Inc
Edwards vs. Zimmer Holdings Inc
Edwards vs. St Jude Medical Inc
Edwards vs. Boston Scientific Corporation
Edwards vs. Smith Nephew plc
Edwards vs. Varian Medical Systems Inc

Edwards May 24 2013 Opportunity Range

Downside Deviation1.92
Information Ratio(0.05)
Maximum Drawdown9.84
Value At Risk(2.58)
Potential Upside2.64

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium